ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Antioxidant treatment could halt neurodegeneration in early Parkinson's

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

Low vitamin D levels predict ED in diabetics

 
Print Page
Email Article

Current Research Updates and News Briefs

  [ 35 votes ]   [ Discuss This Article ]
By Source: Health Watch • www.ProHealth.com • March 1, 1996


Research Updates

A progress report was issued on two of the three CFIDS research centers that are federally subsidized. Both the Boston and Newark (NJ) sites gave a summary of the year to patients; the Denver center has not issued a report yet.

The Boston center published its second paper on the prevalence of CFIDS, and found nearly as many men as women had CFIDS, with a higher frequency in Black and Latino populations. The Boston group continues to seek infectious agents that may cause or contribute to CFIDS as well as muscle abnormalities found in the metabolism. They are also near completion of a study comparing CFIDS to Multiple Sclerosis and depressed patients. Other studies include the quantified electroencephalograph (QEEG) test to study brain waves and the same type of research on neurally mediated hypotension as Johns Hopkins (and are reaching similar conclusions). They do not, however advocate treatment unless a patient has been formally tested and they do not think this is a cue. The Boston group completed and published paper on balance abnormalities, and has 11 other papers being prepared for publication.

Benjamin Natelson, M.D., director of the Newark Center, finished a drug trial using a low dose of the antidepressant pheneizine after a doctor found CFIDS-like symptoms followed high blood pressure treatment. The trial found that, like other antidepressants, it relieved pain. Results from another trial on a similar drug will announce results soon, and a third trial on DHEA, a human hormone, will commence shortly.

Dr. Natelson will collaborate on tests being done at a new Gulf War center. Cooperative studies with the Gulf War Research center has gained the CFIDS center another million-dollar federal grant. In addition, Multiple Chemical Sensitivity (MCS) and its comparison to CFIDS will be the subject of a pilot study at the Robert Wood Johnson Medical School, A study on breathing showed persons with CFIDSs have lower activity of the nerve that controls heart rate, tying into research by Johns Hopkins. They will now start tilt table testing. A fitness study to compare PWCs to deconditioned, sedentary people is also planned.

Assessing Twins with CFS and FMS

Dedra Buchwald, M.D, from the University of Washington in Seattle, has initiated a study of twins to further explore the influences of nature versus nurture. She hopes the study will clarify the importance of predisposing factors that may trigger or contribute to the onset of Chronic Fatigue Syndrome and Fibromyalgia Syndrome. If you are a twin with either CFS or FMS diagnosis and you wish to be part of the study, please contact Nicollete Vajtay, University of Washington, Harborview Medical Center, 325 Ninth Avenue, Box 359780, Seattle, WA 98104, telephone number (206) 731-2125.

Genetic Typing

In 1994, Robert Keller, M.D., and Nancy Klinias, M.D., published a report indicating that certain types of HLA (human leukocyte antigen) class II antigens appeared more commonly in the blood samples of 110 CFS patients versus health controls. Normally a multitude of HLA antigens are present in each cell, and are responsible for detecting foreign or infectious agents and activating the immune system to eradicate the unwanted intruders.

Defects in the HLA system are present in auto-immune disorders like lupus and rheumatoid arthritis, diseases in which certain HLA antigens are present in the blood in higher than normal concentrations. Genetic coding for the HLA system can be found on a specific section (or gene locus) of human chromosome number six. Suspecting that CFS might in some way be tied genetically to the HLA system, Keller and Klimas analyzed their small sample of CFS patients for ten different HLADR antigens and three different HLA-DQ antigens. An increase in the presence of HLADR4, DR5, and DQ3 were found in CFS patients. Klimas says this is "soft" data and that more work with larger patient numbers is needed to be done.

At the October 1995 ACR meeting, Muhammad Yunus, M.D., presented data on HLA typing of 40 multi-case families in which at least two members of the same family had FMA. Dr. Yunus and his associates used sophisticated statistical methods, called sibship test, which examine the linkage of FMS with genetically determined HLS types among blood relatives. They found statistically significant genetic linkage of FMS within the HLA system. Dr. Yunus explained that such findings provide stronger evidence for a genetic role in certain HLA antigens. He also speculated that his findings may be related to previous reports of the high incidence of auto-immune diseases (such as lupus and rheumatoid arthritis) among FMS patients. Why? All HLA codings can be tied to the same area on chromosome number six.

Dr. Yunus said that his positive findings provide the first objective and methodologically reliable demonstration of genetic susceptibility in FMS. However, he cautioned that his data needs to be independently corroborated by others.

In 1995, a conference was sponsored by the Karolinska Institute in Stockholm, Sweden. Members from the U.S. centers participated, and welcomed a new CFS research center in that country.



Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra EPA  - Fish Oil FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Vital Molecule Increases Cellular Energy and Improves Cognitive Function Vital Molecule Increases Cellular Energy and Improves Cognitive Function
Enhance Eyelashes Naturally Enhance Eyelashes Naturally
Probiotic Mint Promotes Healthy Gums & Teeth, Freshens Breath and Whitens Teeth Probiotic Mint Promotes Healthy Gums & Teeth, Freshens Breath and Whitens Teeth
Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance Front Line Defense Against Colds & Flu - Support for Healthy Immune System Balance
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map